Issue Archive
|
Subscribe
|
Editorial Board
|
About
|
Contact
|
Advertise
Home
News
Daily Nephrology News
Daily Urology News
FDA News
Malpractice News
Industry News
Newsletters
Polls & Surveys
Top 10 2008 Stories
Urology
Bladder Cancer
Benign Prostatic Hyperplasia
Erectile Dysfunction
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
Prostate Specific Antigen
Reproductive Medicine
Urinary Incontinence
Urinary Tract Infections
Nephrology
Acute Kidney Injury
Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hyperphosphatemia
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Clinical Trials
Acute Kidney Injury
Bladder Cancer
Diabetes Mellitus
Hemodialysis
Hyperphosphatemia
Kidney/Ureteral Stones
Lupus Nephritis
Nephrogenic Systemic Fibrosis
Overactive Bladder
Pelvic Prolapse
Prostate Cancer
Renal Cell Carcinoma
Renal Obstruction
Renal Transplant
Voiding Dysfunction
Commentary
Conferences
Conference Highlights
Meetings Calendar
Renal Week 2008
30th Annual Dialysis Conference
EAU Conference 2009
NKF 2009
AUA Annual Meeting
ASH Annual Meeting
American Transplant Congress
Canadian Urological Association Annual Meeting
Renal Week 2009
Genitourinary Cancers Symposium
NKF 2010 Spring Meetings
ERA-EDTA 2010 Congress
Expert Series
Jobs
Resources
Links
View Full Issue
Features
World Lit. Review
Legal Issues
Renal Nutrition Update
Your Money
Your Practice
Drug Info
myCME
RSS
|
Login
|
Register
Home
>
Nephrology
> Hypertension
Hypertension
Living Kidney Donor Outcomes Vary by Race
Jody A. Charnow
August 19, 2010
Black and Hispanic living kidney donors are at increased relative risk for hypertension, diabetes requiring drug therapy, and CKD compared with their white counterparts, according to researchers.
Report: Data Do Not Justify Advised BP Goals in CKD
Delicia Honen Yard
August 19, 2010
The target BP level of less than 130/80 mm Hg for CKD patients—which is recommended by a Kidney Disease Outcomes Quality Initiative guideline—is not definitively supported by scientific data and could potentially lead to adverse effects, according to Julia B. Lewis, MD, of the division of nephrology and hypertension at Vanderbilt University School of Medicine in Nashville.
Electronic Records May Help Improve BP Control
John Schieszer
July 28, 2010
NEW YORK—New findings suggest that electronic health records (EHR) with special features for managing hypertension may be highly beneficial in improving BP control.
Studies Support Earlier Intervention
John Schieszer
July 27, 2010
Doctors may be able to head off ESRD and CVD by treating pre-diabetes and pre-hypertension sooner.
BP Lowering Better with a Triple Regimen
John Schieszer
July 12, 2010
NEW YORK—An investigational triple regimen of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) may result in significantly greater mean reductions in BP compared with a combination of any two of these drugs in patients with moderate to severe hypertension, new data show.
Increased Hypertension Risk Found in Live Kidney Donors
Jody A. Charnow
June 26, 2010
MUNICH, GERMANY—Live kidney donors may experience an increase in blood pressure following nephrectomy, new data suggest.
BP Guidelines May be Inappropriate for HD Patients
John Schieszer
May 21, 2010
SEATTLE—Guidelines recommend that hemodialysis (HD) patients have predialysis BP levels below 140/90 mm Hg, but study findings suggest that such levels may increase their risk of death, according to David Goodkin, MD, an investigator with Arbor Research Collaborative for Health.
New Formulation of PAH Medication Is Now Available
Jody A. Charnow
May 21, 2010
Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, is now commercially available, according to the drug's maker, Actelion Pharmaceuticals US, Inc., of South San Francisco, Calif.
Olmesartan Cleared for Treating Hypertension in Children
Jody A. Charnow
March 30, 2010
The FDA approved the use of Benicar (olmesartan medoxomil) for the treatment of hypertension in individuals aged 6 to 16 years. The drug original was cleared in 2002 for the treatment of adult hypertension.
Resistant Hypertension Tied to Less Sleep
Jody A. Charnow
March 30, 2010
Short sleep time and poor sleep efficiency may have an etiologic role.
more »
Visit our
Conference Highlights
section for news from recent meetings, including our coverage of the American Transplant Congress.
Your Money
Visit
Your Money
for the latest financial news and advice.
Stay up to date on the latest
Legal Issues
affecting urologists and nephrologists.
Our
World Literature Review
department has information on the latest nephrology and urology studies from around the world.
Renal & Urology News
E-Newsletters
Sign up today
to start receiving one of three free e-newsletters from Renal & Urology News or get them all.
- eTOC (print edition preview)
- RUN Roundup
- Conference Highlights
Sample
|
Subscribe
|
Archive
Most Popular
Most Emailed
Most Recent
Ambiguities of the Prostate: Searching for Beacons in the Fog
Caesarean Births Lower Prolapse Risk
Potential Gene Biomarkers for OAB Identified
Acute Graft Pyelonephritis Does Not Adversely Affect Long-Term Transplant Outcomes
ED Drugs Can Ease Post-Op Urinary Incontinence
Modified TVT-O Technique Effective in Easing SUI
Stone Formers Found to Be at Higher Risk for MI
Surveillance a Suitable Option for Low-Risk PCa
Post-RP Statins May Lower PSA Relapse Risk
Living Kidney Donor Outcomes Vary by Race
Unique Treatment Raises Tricky Bioethical Issues
Aspirin Use May Decrease Prostate Cancer Risk
Managing Metabolic Acidosis in CKD Patients
Death Risk in Hemodialysis Patients Linked to Potassium
Gastric Bypass Superior to Diet for Diabetics
Ambiguities of the Prostate: Searching for Beacons in the Fog
Cardiovascular Events Halt Study of Testosterone Gel
Metformin Benefits Diabetics with Heart Failure
Statins Are Underused in Type 2 Diabetics
CKD in Non-Renal Transplant Recipients On the Rise
Modified TVT-O Technique Effective in Easing SUI
ED Drugs Can Ease Post-Op Urinary Incontinence
Potential Gene Biomarkers for OAB Identified
Acute Graft Pyelonephritis Does Not Adversely Affect Long-Term Transplant Outcomes
Ambiguities of the Prostate: Searching for Beacons in the Fog
Caesarean Births Lower Prolapse Risk
Stone Formers Found to Be at Higher Risk for MI
Surveillance a Suitable Option for Low-Risk PCa
Post-RP Statins May Lower PSA Relapse Risk
Living Kidney Donor Outcomes Vary by Race
Popular Topics
Acute Kidney Injury
Anemia
Bladder Cancer
BPH
Cardiovascular Disease
Chronic Kidney Disease
CKD
Diabetes
Dialysis
Epidemiology
Erectile Dysfunction
Hemodialysis
Hyperphosphatemia
Hypertension
Infection
Kidney Cancer
Kidney Stones
Peritoneal Dialysis
Prostate Cancer
PSA
Reproductive Medicine
Secondary Hyperparathyroidism
Transplantation
Urinary Incontinence
UTI
Sponsored Links